Zobrazeno 1 - 10
of 146
pro vyhledávání: '"Wayne, Gulliver"'
Autor:
Audrey Bui, Sugandh Kumar, Jared Liu, Faye Orcales, Susanne Gulliver, Lam C. Tsoi, Wayne Gulliver, Wilson Liao
Publikováno v:
Frontiers in Genetics, Vol 14 (2023)
Psoriasis is an immune-mediated inflammatory skin disease typically characterized by erythematous and scaly plaques. It affects 3% of the Newfoundland population while only affecting 1.7% of the general Canadian population. Recent genome-wide associa
Externí odkaz:
https://doaj.org/article/dff61e8cffd64a5a80656b21b64879e7
Autor:
Joseph F Merola, Lihi Eder, Proton Rahman, Soumya D Chakravarty, Jose U Scher, Alexis Ogdie, Rebecca B Blank, Vincent Piguet, C T Ritchlin, Jonathan Samuels, Kun Qian, Wayne Gulliver, Ralf G Thiele, Rebecca H Haberman, Rochelle Castillo, Cinty Gong, Andrea L Neimann, Katrina A MacFarlane, Sydney Catron, Michael Toprover, Zakwan Uddin, Jiyuan Hu, Francisco Tausk, Jensen Yeung
Publikováno v:
BMJ Open, Vol 12, Iss 12 (2022)
Introduction Psoriatic arthritis (PsA) is a complex, immune-mediated disease associated with skin psoriasis that, if left untreated, can lead to joint destruction. Up to 30% of patients with psoriasis progress to PsA. In most cases, psoriasis precede
Externí odkaz:
https://doaj.org/article/00532788ed73452a9549d4940f407895
Autor:
Winifred Badaiki, Evelyn Pyper, Kendra Lester, Janelle Skeard, Michelle Penney, Janey Shin, Brenda Fisher, Huong Hew, Susanne Gulliver, Wayne Gulliver, Proton Rahman
Publikováno v:
International Journal of Population Data Science, Vol 7, Iss 1 (2022)
The Janssen and Newfoundland and Labrador Health Innovation Partnership (JANL-HIP) was established to carry out Real-World Evidence (RWE) projects to generate evidence about disease pathways, healthcare delivery, the effects of clinical interventions
Externí odkaz:
https://doaj.org/article/b822f14c00d44ed382be84d8483b3a57
Autor:
Priyanka Karagaiah, Steven Daveluy, Alex Ortega-Loayza, Wayne Gulliver, Jacek Szepietowski, Stephan Grabbe, Mohamad Goldust
Publikováno v:
Journal of Drugs in Dermatology. 22:369-374
Autor:
Wayne Gulliver, Melinda J. Gooderham, Baojin Zhu, Christian Jossart, Sonia Montmayeur, Russel Burge, Catherine Reed
Publikováno v:
Dermatology and Therapy. 13:235-244
Patients with psoriasis (PsO) should adhere to and be persistent with treatment to maintain disease control. Patient support programs (PSPs) are useful to support patients with disease management. We aimed to understand the real-world patient profile
Autor:
Caterina, Zagona-Prizio, Jenna, Yousif, Carly, Grant, Manan, Mehta, David, Rosmarin, Nanette, Silverberg, Jerry, Tan, Cecilia, Larocca, Michi, Shinohara, Arash, Mostaghimi, Brian, Kim, Susanne, Gulliver, Wayne, Gulliver, Daniel, Siegel, Lourdes, Perez-Chada, Joseph, Merola, Alice, Gottlieb, April, Armstrong
Publikováno v:
Journal of Drugs in Dermatology. 21:867-874
International Dermatology Outcome Measures (IDEOM) is a non-profit organization founded in 2013. It is composed of researchers and stakeholders who work to develop evidenced-based outcome measures to enhance research and treatment recommendations of
Autor:
Thrasivoulos Tzellos, Kelsey R. van Straalen, Athanassios Kyrgidis, Afsaneh Alavi, Noah Goldfarb, Wayne Gulliver, Gregor B. E. Jemec, Michelle A. Lowes, Angelo Valerio Marzano, Errol P. Prens, Christopher J. Sayed, Hessel H. van der Zee, Christos C. Zouboulis
Publikováno v:
Journal of the European Academy of Dermatology and Venereology, 37(2), 395-401. Wiley-Blackwell
Tzellos, T, van Straalen, K R, Kyrgidis, A, Alavi, A, Goldfarb, N, Gulliver, W, Jemec, G B E, Lowes, M A, Marzano, A V, Prens, E P, Sayed, C J, van der Zee, H H & Zouboulis, C C 2023, ' Development and validation of IHS4-55, an IHS4 dichotomous outcome to assess treatment effect for hidradenitis suppurativa ', Journal of the European Academy of Dermatology and Venereology, vol. 37, no. 2, pp. 395-401 . https://doi.org/10.1111/jdv.18632
Tzellos, T, van Straalen, K R, Kyrgidis, A, Alavi, A, Goldfarb, N, Gulliver, W, Jemec, G B E, Lowes, M A, Marzano, A V, Prens, E P, Sayed, C J, van der Zee, H H & Zouboulis, C C 2023, ' Development and validation of IHS4-55, an IHS4 dichotomous outcome to assess treatment effect for hidradenitis suppurativa ', Journal of the European Academy of Dermatology and Venereology, vol. 37, no. 2, pp. 395-401 . https://doi.org/10.1111/jdv.18632
Background: Validated, inclusive and easy-to-use outcomes for hidradenitis suppurativa are essential both in the clinical trial setting and clinical practice. The continuous IHS4 is a validated tool that dynamically assesses nodules/abscesses/drainin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e1a8f33df6b7c9a7a2eaa276267abf7
https://pure.eur.nl/en/publications/2062a880-3b37-4d25-b4cf-fb60f2805927
https://pure.eur.nl/en/publications/2062a880-3b37-4d25-b4cf-fb60f2805927
Autor:
Kelsey R. van Straalen, Thrasyvoulos Tzellos, Afsaneh Alavi, Farida Benhadou, Carlos Cuenca-Barrales, Mathilde Daxhelet, Mathieu Daoud, Ourania Efthymiou, Evangelos J. Giamarellos-Bourboulis, Philippe Guillem, Wayne Gulliver, Gregor Borut Ernst Jemec, Alexandros Katoulis, Anke Koenig, Elizabeth Lazaridou, Michelle A. Lowes, Angelo V. Marzano, Łukasz Matusiak, Alejandro Molina-Leyva, Chiara Moltrasio, Andreas Pinter, Concetta Potenza, Errol P. Prens, Jorge Romaní, Ditte Marie L. Saunte, Christopher J Sayed, Nevena Skroza, Dimitra Stergianou, Jacek C. Szepietowski, Anastasia Trigoni, Eva Vilarrasa, Athanassios Kyrgidis, Christos C. Zouboulis, Hessel H. van der Zee
Publikováno v:
Dermatology.
Background: Previously, a new dichotomous outcome was developed, calculated as 55% reduction in the International Hidradenitis Suppurativa 4 score (IHS4-55). It was validated in datasets of adalimumab and placebo treated HS patients. External validat
Autor:
François, Lagacé, Elena, Netchiporouk, Irina, Turchin, Wayne, Gulliver, Jan, Dutz, Mark G, Kirchhof, Popradi, Popradi, Robert, Gniadecki, Charles, Lynde, Ivan V, Litvinov
Publikováno v:
Skin therapy letter. 27(5)
Extracorporeal photopheresis (ECP) is an immunomodulatory therapy that has been used for over 35 years to treat numerous conditions. ECP was initially approved by the US FDA in 1988 for the treatment of Sézary syndrome, a leukemic form of cutaneous
Autor:
Matthew Nelder, Farrell Cahill, Hongwei Zhang, Guangju Zhai, Wayne Gulliver, Weiping Teng, Zhongyan Shan, Guang Sun
Publikováno v:
Frontiers in Endocrinology, Vol 9 (2018)
Background: Our previous study of 29 obese food addiction (FA) patients found that FA is associated with lipid profiles and hormones which may be a factor in cardiovascular disease (CVD) and insulin resistance (IR). However, there is currently no dat
Externí odkaz:
https://doaj.org/article/c67647ae20d149c29007aca1d2193159